Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 11 member 2 (SLC11A2), also known as divalent metal transporter 1 (DMT1), is an integral membrane transporter critical for the absorption and intracellular transport of divalent metal ions, especially iron (Fe²⁺) and manganese (Mn²⁺). SLC11A2 is expressed in the duodenal brush border for dietary iron uptake and in endosomal membranes for iron export into the cytoplasm. It is regulated by body iron stores to maintain iron homeostasis and is involved in erythropoiesis, mitochondrial function, and modulation of iron and manganese entry into the brain. Mutations and altered expression of SLC11A2 are implicated in iron-related anemias, neurodegenerative diseases, and systemic metal toxicity. Its broad selectivity for multiple divalent cations underlies both its physiological importance and associated safety concerns for metal overload.
Drugs may act by modulating iron and manganese uptake, chelating excess metals to reduce toxicity, or influencing SLC11A2 expression or localization
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 11 member 2 (SLC11A2).